The information within this section of the website is intended for UK Healthcare Professionals. Members of the public, Prostap DCS prescribed patients and UK Practice Managers should follow the relevant links.

Feel comfortable with the device

Quick and easy to administer7,8

comfortablewithadministration-figure1

This 3-minute video will help you feel comfortable administering Prostap DCS. It explains the simple steps required and highlights the advantages of the safety device.

Preferred by nurses20

In a Takeda sponsored survey of 100 nurses (urology nurses, cancer nurse specialists, practice nurses) with experience administering Prostap DCS and Zoladex® (goserelin acetate) and/or Decapeptyl® (triptorelin), Prostap DCS was considered to be significantly:

Zoladex® is a registered trademark of AstraZeneca.
Decapeptyl®  is a registered trademark of Ipsen Pharma.

Preferred by nurses21

If choosing to administer an LHRH agonist to a close friend or relative, Prostap DCS was the first choice for the majority of nurses surveyed (n=100):

comfortablewithadministration-figure3

Zoladex® is a registered trademark of AstraZeneca.
Decapeptyl® is a registered trademark of Ipsen Pharma.

Contact

If you are a healthcare professional and have a query about Prostap DCS, please call Medical Information on:

01628 537 900

If you would like to find out more about how Prostap DCS can help your practice save money, or to order, please call CLARITYpharma on:

0845 080 5190

If you are a healthcare professional and would like to be contacted about Prostap DCS, please enter your details in the short form below

Your Name
Email
Phone
Definition of Role
Practice address
Postcode
*Required fields

Takeda UK Ltd will NOT share any of your details with any other parties. If at any time you wish to unsubscribe from receiving information about Prostap DCS, please call Takeda UK Ltd on 01628 537 900.

References

  1. Takeda UK Ltd. Data on file, DF120604(2).
  2. The Leuprolide Study Group. N Eng J Med 1984;311:1281–1286.
  3. Sharifi R, Ratanawong C et al. Advanced Drug Delivery Reviews 1977;28:121–138.
  4. D’Amico A V, Chen M et al. JAMA 2008;299:289–295.
  5. Kienle E, Lubben G. Urol Int 1996;56(Suppl 1):23–30.
  6. Tunn U W, Wiedey K. Prostate Cancer Prostatic Dis 2009;12:83–87.
  7. Prostap SR DCS. Summary of Product Characteristics.
  8. Prostap 3 DCS. Summary of Product Characteristics.
  9. PharmaTimes online. Takeda launches new presentation of Prostap, 2011. Available at:
    http://www.pharmatimes.com/news/takeda_launches_new_presentation_of_prostap_980760 Last accessed April 2019.
  10. Health and Safety Sharp Instruments in Healthcare Regulations 2013. Available at: http://www.hse.gov.uk/pubns/hsis7.pdf. Last accessed April 2019.
  11. National Institute for Health and Care Excellence (NICE). Clinical guideline CG175. Full guideline, 2014.
  12. Abdouelfadel Z & Crawford D. Therapeut Clin Risk Manag 2008;4(2):513–526.
  13. Barnes R et al. Study M86-049 Report.
  14. MHRA Prostap® SR DCS UKPAR, 2014. Available at: http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con120
    442.pdf
    . Last accessed April 2019.
  15. Jocham D. Urol Int 1998;60:18–24.
  16. Mottet N et al. European Association of Urology Guidelines on Prostate Cancer. Update 2018.
  17. D’Amico et al. JAMA 2004;292(7):821–827.
  18. Mottet N et al. Eur Urol 2012;62:213–219.
  19. Wechsel HW et al. Eur Urol 1996;30(Suppl 1):7–14.
  20. Takeda UK Ltd. Data on file. DF121104.
  21. Takeda UK Ltd. Data on file. DF121106.

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for Practice Managers.

If you are not a Practice Manager, please select the appropriate area of this website from the welcome page.

No

I am not a
Practice Manager

Yes

I am a
Practice Manager

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for Healthcare Professionals.

If you are not a Healthcare Professional, please select NO to go back and select the appropriate section of this website for you.

No

I am not a Healthcare Professional

Yes

I am a Healthcare Professional interested in prostate cancer

Yes

I am a Healthcare Professional interested in endometriosis

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for patients who have been prescribed Prostap DCS.

If you are not a patient who has been prescribed Prostap DCS, please select the appropriate area of this website from the welcome page.

No

I am not a Prostap DCS prescribed patient.

Yes

I am a Prostap DCS prescribed patient.